Anti-Interleukin (IL)-21 Monoclonal Antibody Reduces Disease Severity and Inflammatory Cytokines in Murine Colitis

被引：0
|
作者：
Lewis, Katherine E.
Bilsborough, Janine
Maurer, Mark F.
Bontadelli, Kristen
Waggie, Kim
Krejsa, Cecile M.
Dillon, Stacey R.
机构：
来源：
GASTROENTEROLOGY | 2009年 / 136卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A47 / A48
页数：2
相关论文
共 50 条
  • [21] Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice
    Elson, Charles O.
    Cong, Yingzi
    Weaver, Casey T.
    Schoeb, Trenton R.
    McClanahan, Terrill K.
    Fick, Robert B.
    Kastelein, Robert A.
    GASTROENTEROLOGY, 2007, 132 (07) : 2359 - 2370
  • [22] Effect of intravitreal injection of anti-interleukin (IL)-6 antibody in experimental autoimmune uveitis in mice
    Hoesel, Kristin
    Chasan, Buesra
    Tode, Jan
    Rose-John, Stefan
    Roider, Johann Baptist
    Ehlken, Christoph
    JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION, 2024, 14 (01):
  • [23] Intravitreal injection of anti-Interleukin (IL)-6 antibody attenuates experimental autoimmune uveitis in mice
    Tode, Jan
    Richert, Elisabeth
    Koinzer, Stefan
    Klettner, Alexa
    Pickhinke, Ute
    Garbers, Christoph
    Rose-John, Stefan
    Noelle, Bernhard
    Roider, Johann
    CYTOKINE, 2017, 96 : 8 - 15
  • [24] Neutralization of Interleukin 21 Using a Monoclonal Antibody Results in Suppression of Experimental Colitis
    Holm, Thomas
    Kvist, Peter
    Sondergaard, Henrik
    Frederiksen, Klaus
    Lundsgaard, Dorthe
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S648 - S648
  • [25] Efficacy and Safety of Anti-Interleukin 6 Receptor Monoclonal Antibody (Tocilizumab) in Colombian Patients With Takayasu Arteritis
    Alberto Canas, Carlos
    Canas, Felipe
    Hernan Izquierdo, Jorge
    Echeverri, Andres-Felipe
    Mejia, Mauricio
    Bonilla-Abadia, Fabio
    Tobon, Gabriel J.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2014, 20 (03) : 125 - 129
  • [26] Phase I, multicenter trial of CNTO 328, an anti-interleukin(IL)-6 monoclonal antibody (mAb) in subjects with selected hematologic malignancies.
    Kurzrock, R.
    Voorhees, P.
    Fayad, L.
    Orlowski, R.
    Van Rhee, F.
    Furman, R.
    Borghaei, H.
    Zaki, M. H.
    Prabhakar, U.
    Garay, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 103S - 103S
  • [27] Treatment with Anti-Interleukin 23 Antibody Ameliorates Disease in Lupus-Prone Mice
    Kyttaris, Vasileios C.
    Kampagianni, Ourania
    Tsokos, George C.
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [28] Therapeutic effects of anti-interleukin 8 monoclonal antibody on antigen-induced arthritis in rabbit.
    Akahoshi, T
    Nishimura, A
    Takahashi, M
    Hosaka, S
    Takagishi, K
    Itoman, M
    Kondo, H
    Matsushima, K
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1316 - 1316
  • [29] Preliminary results of CNTO 328, an anti-interleukin (IL)-6 monoclonal antibody (mAb), in combination with bortezomib in the treatment of relapsed or refractory multiple myeloma
    Manges, Robert F.
    Sutherland, Heather J.
    Jagannath, Sundar
    Orlowski, Robert Z.
    La Police, David
    DeWitte, Mark
    Lang, Zhihui
    Corringham, Robert E.
    Rossi, Jean Francois
    BLOOD, 2007, 110 (11) : 358A - 359A
  • [30] Efficacy and Safety of Guselkumab, an Anti-interleukin 23 Monoclonal Antibody, for Palmoplantar Pustulosis A Randomized Clinical Trial
    Terui, Tadashi
    Kobayashi, Satomi
    Okubo, Yukari
    Murakami, Masamoto
    Hirose, Keiichiro
    Kubo, Hiroshi
    JAMA DERMATOLOGY, 2018, 154 (03) : 309 - 316
12345